Clinical trial
Molecular Culture for the Diagnosis of Neonatal Sepsis: Towards Faster Recognition of Uninfected Neonates and Better Antibiotic Stewardship
NCT05763680 is registered in ClinicalTrials.gov with Jip Groen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Culture for the Diagnosis of Neonatal Sepsis: Towards Faster Recognition of Uninfected Neonates and Better Antibiotic Stewardship
- Lead sponsor
- Jip Groen
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 15, 2023
- Completion date
- August 31, 2025
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clinical sepsis, culture negative neonatal sepsis, culture positive neonatal sepsis, microbial colonization, microbial disease, neonatal infection, neonatal sepsis, early-onset, neonatal sepsis, late-onset